|

Placebo (PB) Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Regeneron Pharmaceuticals2

Indications

  • Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)1
  • Mutation in the Superoxide Dismutase-1 (SOD1) Gene1
  • Amyotrophic Lateral Sclerosis (ALS)1
  • Liver Disease1
  • Multiple Sclerosis1

Other1 trial

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Phase 1/2

Glendale, California1 trial

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

California Clinical Trials Medical Group

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.